11/19
11:40 am
agl
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
11/19
11:40 am
agl
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Low
Report
agilon health, inc. (NYSE: AGL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
11/19
11:21 am
agl
Rating for AGL
Low
Report
Rating for AGL
11/19
11:21 am
agl
Rating for AGL
Low
Report
Rating for AGL
11/13
12:50 pm
agl
Rating for AGL
Low
Report
Rating for AGL
11/13
12:50 pm
agl
Rating for AGL
Low
Report
Rating for AGL
11/12
12:59 pm
agl
Rating for AGL
Low
Report
Rating for AGL
11/11
08:59 am
agl
Rating for AGL
High
Report
Rating for AGL
11/11
08:59 am
agl
Rating for AGL
High
Report
Rating for AGL
11/11
07:47 am
agl
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
High
Report
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
11/11
07:47 am
agl
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
High
Report
agilon health, inc. (NYSE: AGL) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
11/11
05:28 am
agl
Rating for AGL
High
Report
Rating for AGL
11/11
05:28 am
agl
Rating for AGL
High
Report
Rating for AGL
11/8
08:08 am
agl
Rating for AGL
Low
Report
Rating for AGL
11/8
08:08 am
agl
Rating for AGL
Low
Report
Rating for AGL
10/29
06:19 pm
agl
agilon health, inc. (NYSE: AGL) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $2.50 price target on the stock, down previously from $7.00.
Report
agilon health, inc. (NYSE: AGL) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $2.50 price target on the stock, down previously from $7.00.
10/29
05:55 pm
agl
Rating for AGL
Low
Report
Rating for AGL
10/29
05:55 pm
agl
Rating for AGL
Low
Report
Rating for AGL
10/8
12:52 pm
agl
Rating for AGL
Low
Report
Rating for AGL